Plasmonics,
especially the localized surface plasmon resonance
(LSPR) in non-noble metal bismuth nanoparticles (Bi NPs), and its
spectral features and applications have stimulated increasing research
interest in recent years. However, the lack of mature methods to prepare
Bi NPs with a well-controlled size and/or shape significantly limits
the experimental investigations concerning the LSPR optical properties.
Herein, we realize the size-tunable synthesis of nearly monodisperse
spherical Bi NPs through a thiolate pyrolysis reaction in solution.
The instantaneous thermolysis of a layered molecular intermediate,
bismuth dodecanethiolate [Bi(SC12H25)3], results in a classical LaMer mechanism for the nucleation and
growth of Bi NPs, allowing for a precise size control from 65 to 205
nm in the average diameter. The diameter tunability enables a systematic
study on the size dependence of LSPR optical properties of Bi NPs,
and we observe rich ultraviolet–visible–near-infrared
spectral responses arising from the LSPR absorption and scattering
of Bi NPs as their size varies, which will greatly benefit the light
harvesting and manipulation in the solar spectrum. Furthermore, we
find that a complete oxidation occurs to Bi NPs under air flow at
the temperature when they melt and accordingly generate metastable
tetragonal-phase β-Bi2O3 NPs that show
an optical band gap of 2.15 eV and interesting temperature-dependent
β → α → δ → (γ + β)
polymorphic transitions.
The growth of metal chalcogenide nanowires (NWs) on metal substrates is a challenging work since the direct reactions taking place between chalcogen (S, Se or Te) and zero-valent metal (M0)...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.